Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

The Effect of Motivational Interviewing on Smoking Behavior Among Nursing Students

10 août 2026 mis à jour par: Meral Feratoğlu Research

The Effect of Motivational Interviewing on Changing Smoking Behavior Among Nursing Students

Smoking is one of the leading preventable public health problems worldwide, particularly among young adults who are at increased risk of nicotine dependence. Nursing students represent an important target population because, as future health professionals, they are expected to play a significant role in tobacco control and smoking cessation counseling. The Transtheoretical Model (TTM) is one of the most widely used theoretical frameworks for promoting health behavior change. The aim of this study will be to determine the effect of Transtheoretical Model-based motivational interviewing on changing smoking behavior among nursing students.

This study will be planned as a single-group, quasi-experimental pretest-posttest intervention. Nursing students who smoke cigarettes and voluntarily agree to participate will be included in the study. At baseline, participants will complete a Demographic Information Form, the Fagerström Test for Nicotine Dependence, the Stages of Change questionnaire, the Self-Efficacy/Temptation Scale, the Processes of Change Scale, and the Decisional Balance Scale.

Participants will receive Transtheoretical Model-based educational sessions and motivational interviewing interventions focusing on the health effects of smoking, reasons for smoking, the benefits of smoking cessation, identification of social support resources, relapse prevention strategies, and successful smoking cessation experiences. The Stages of Change questionnaire will be administered before each motivational interviewing session, and all outcome measures will be reassessed during follow-up evaluations. The study is expected to provide evidence regarding the effectiveness of Transtheoretical Model-based motivational interviewing in reducing smoking behavior, decreasing nicotine dependence, promoting progression through the stages of change, improving self-efficacy, enhancing the use of behavioral change processes, and supporting smoking cessation among nursing students.

Aperçu de l'étude

Statut

Pas encore de recrutement

Les conditions

Type d'étude

Interventionnel

Inscription (Estimé)

87

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Lieux d'étude

    • Kırklareli
      • Kırklareli, Kırklareli, Turquie (Türkiye), 39100
        • Kırklareli University Faculty of Health Sciences
        • Contact:

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte
  • Adulte plus âgé

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

  • Nursing students currently enrolled in the study setting.
  • Aged 18 years or older.
  • Current cigarette smokers.
  • No self-reported health condition that would prevent participation in the intervention.
  • Willing and able to provide informed consent and participate in the study.

Exclusion Criteria:

  • Inability to complete all planned stages of the study.
  • Withdrawal of consent or voluntary discontinuation from the study at any time.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: N / A
  • Modèle interventionnel: Affectation à un seul groupe
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Motivational Interviewing
Participants will receive a Transtheoretical Model-based motivational interviewing intervention designed to promote smoking behavior change and smoking cessation. The intervention will consist of structured face-to-face motivational interviewing sessions delivered in groups, supported by educational content on the health effects of smoking, benefits of smoking cessation, behavior change strategies, social support, relapse prevention, and self-efficacy enhancement. Outcomes will be evaluated using validated questionnaires administered at baseline and follow-up assessments.
Participants will receive a Transtheoretical Model-based motivational interviewing intervention to promote smoking behavior change and smoking cessation. Face-to-face motivational interviewing sessions will be conducted by a researcher trained in motivational interviewing. According to the intervention protocol, participants may receive between two and six sessions depending on their readiness to change, individual needs, and continued participation throughout the study. The intervention will include counseling and education on smoking-related health risks, smoking cessation, motivation enhancement, self-efficacy, behavior change strategies, social support, and relapse prevention. Participants' stage of change will be assessed before each session, and the intervention will be tailored accordingly. Outcomes will be evaluated using validated instruments measuring smoking behavior, nicotine dependence, stages of change, self-efficacy, and behavior change processes.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Change in Smoking Behavior
Délai: Baseline, Mid-intervention Assessment (1 month), Post-intervention Assessment (2 months)
The primary outcome is the change in smoking behavior following the Transtheoretical Model-based motivational interviewing intervention. Smoking behavior will be evaluated by the average number of cigarettes smoked per day and smoking cessation status.
Baseline, Mid-intervention Assessment (1 month), Post-intervention Assessment (2 months)

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Change in Nicotine Dependence
Délai: Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
Nicotine dependence will be assessed using the Fagerström Test for Nicotine Dependence (FTND). The total score ranges from 0 to 10, with higher scores indicating a higher level of nicotine dependence.
Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
Change in Processes of Change
Délai: Baseline, Mid-intervention Assessment( 1 month later), Post-intervention Assessment (2 months later)
Behavioral change processes will be assessed using the Processes of Change Scale. The total score ranges from 22 to 110, with higher scores indicating greater use of behavioral change processes related to smoking cessation.
Baseline, Mid-intervention Assessment( 1 month later), Post-intervention Assessment (2 months later)
Change in Self-Efficacy/Temptation for Smoking Cessation
Délai: Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
Self-efficacy related to smoking cessation will be assessed using the Self-Efficacy/Temptation Scale. The scale consists of 8 items rated on a 5-point Likert scale, with a total score ranging from 8 to 40. Higher scores indicate greater self-efficacy and greater confidence in the ability to refrain from smoking in situations that may trigger the urge to smoke.
Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
Change in Decisional Balance
Délai: Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
Decisional balance related to smoking cessation will be assessed using the Decisional Balance Scale. The scale consists of 12 items rated on a 5-point Likert scale, with a total score ranging from 12 to 60. Higher scores indicate greater perceived importance of the benefits and barriers of change and greater engagement in the decision-making process related to smoking cessation.
Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

1 août 2026

Achèvement primaire (Estimé)

1 septembre 2026

Achèvement de l'étude (Estimé)

1 décembre 2026

Dates d'inscription aux études

Première soumission

5 août 2026

Première soumission répondant aux critères de contrôle qualité

10 août 2026

Première publication (Réel)

11 août 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

11 août 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

10 août 2026

Dernière vérification

1 août 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner